KLTO
Klotho Neurosciences Inc.

3,714
Mkt Cap
$16.24M
Volume
248,297.00
52W High
$3.91
52W Low
$0.1135
PE Ratio
-0.68
KLTO Fundamentals
Price
$0.2209
Prev Close
$0.218
Open
$0.2158
50D MA
$0.3323
Beta
1.32
Avg. Volume
623,158.25
EPS (Annual)
-$0.3195
P/B
1.57
Rev/Employee
$0.00
$9.54
Loading...
Loading...
News
all
press releases
Klotho Neurosciences to Present at the Biotech Showcase 2026
Klotho Neurosciences to Present at the Biotech Showcase 2026 Klotho Neurosciences to Present at the Biotech Showcase 2026 PR Newswire NEW YORK, Jan. 8, 2026 NEW YORK, Jan. 8, 2026 /PRNewswire...
PR Newswire·1mo ago
News Placeholder
More News
News Placeholder
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award...
PR Newswire·3mo ago
News Placeholder
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston PR Newswire NEW YORK, Oct. 16, 2025 NEW YORK, Oct. 16, 2025...
PR Newswire·4mo ago
News Placeholder
Klotho Neurosciences Stock Jumps As FDA Grants Orphan Drug Tag To ALS Gene Therapy
The FDA’s Orphan Drug Designation offers incentives like seven years of U.S. market exclusivity, tax credits for clinical trials, and a waiver of the user fee for its ALS gene therapy.
Stocktwits·7mo ago
News Placeholder
Klotho Neurosciences Stock Skyrockets On Anti-Aging Gene Therapy Breakthrough: Retail Traders Over The Moon
The gene therapy, delivered via the AAV9 vector, showed positive effects in both standard and accelerated aging models.
Stocktwits·8mo ago
<
...
1
>

Latest KLTO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.